💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

German exporters pinched by 70-billion-euro price squeeze - DIHK

Published 08/24/2022, 09:55 AM
Updated 08/24/2022, 10:01 AM
© Reuters. FILE PHOTO: An aerial view shows the terminal of German company BLG, which is specialized in cars export, in a harbour in Hamburg, Germany, April 27, 2022.REUTERS/Fabian Bimmer

By Rene Wagner

BERLIN (Reuters) - German exporters are in an "extreme price squeeze" and incurred extra costs of 70 billion euros ($69 billion) this year due to soaring producer and import prices, the Association of German Chambers of Industry and Commerce (DIHK) said on Wednesday.

According to surveys and calculations made by the Association, German companies raised the prices of their exported goods by 14.7% in the first half of the year, but producer and import prices rose about twice as fast.

"The resulting burden on German foreign trade amounts to 70 billion euros for the first six months alone," Volker Treier, head of foreign trade at DIHK, told Reuters.

"German foreign trade finds itself in an extreme price squeeze, from which it will not be able to free itself in the next few months," said Treier, as companies only pass on part of their higher costs to overseas customers.

One issue is the weakness of the euro currency, which has fallen below parity with the dollar and tumbled to its lowest level in two decades, often making imported goods costlier.

Despite Russia's invasion of Ukraine, supply shortages and coronavirus lockdowns in China, German exports actually increased by 13% in the first half of the year.

But according to DIHK calculations, adjusted for inflation, the real values ​​are negative: exports have fallen by 1.5%.

"This means that German foreign trade is already in a recessionary phase," said Treier.

According to the latest DIHK business survey, companies in key export sectors are particularly squeezed. For example, 17% of vehicle makers say they will not pass on cost increases to customers, and 35% of pharmaceutical companies also will not.

© Reuters. FILE PHOTO: An aerial view shows the terminal of German company BLG, which is specialized in cars export, in a harbour in Hamburg, Germany, April 27, 2022.REUTERS/Fabian Bimmer

"Currently there are no signs that this tense situation will be resolved quickly," said Treier, adding that some companies also feared weakening demand in major markets China and the United States.

($1 = 1.0085 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.